tianeptine (Stablon)

Subscribe to Selected New Research on tianeptine

96 relevant articles (16 outcomes, 29 trials/studies) found for this Bio-Agent

Description: structure given in first source

Also Known As:

Stablon; (3-chloro-6-methyl-5,5-dioxo-6,11-dihydrodibenzo(c,f)(1,2)thiazepin-11-yl)-7-aminoheptanoic acid; Ardix brand of tianeptine, monosodium salt; tianeptine, (+-)-isomer; tianeptine, monosodium salt; tianeptine, monosodium salt, (+-)-isomer

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Experts

1.	Kayir, Hakan: 3 articles (02/2007 - 03/2005)
2.	Levin, O S: 2 articles (05/2007 - 01/2006)
3.	Ceyhan, Mert: 2 articles (02/2007 - 03/2005)
4.	Osmundsen, Harald: 2 articles (07/2006 - 02/2006)
5.	Gundersen, Yngvar: 2 articles (07/2006 - 02/2006)
6.	Opstad, Per Kristian: 2 articles (07/2006 - 02/2006)
7.	Fonnum, Frode: 2 articles (07/2006 - 02/2006)
8.	Breivik, Torbjørn: 2 articles (07/2006 - 02/2006)
9.	Karpov, Iu A: 2 articles (01/2006 - 01/2006)
10.	Riabykina, G V: 2 articles (01/2006 - 01/2006)

Related Diseases

1.	Depressive Disorder (Melancholia) 03/01/1995 - "Preliminary evidence suggests that tianeptine may also be effective in patients with endogenous depression" 01/01/1988 - "The authors have concluded that tianeptine is effective in depressive disorders as shown both by depression rating scales and subjective impressions of treated patients" 06/01/2005 - "Together with clinical data on the efficacy of tianeptine as an antidepressant, these actions offer insights into how compounds like tianeptine may be useful in the treatment of neurobiological features of depressive disorders." 01/01/2005 - "Of 80 patients with anxiety-depressive disorders studied on days 15-30 after onset of disease, 30 received tianeptine (37.5 mg/day) for 3-6 months and 50 comprised control group" 01/01/2004 - "Tianeptine (coaxil) was used in the treatment of 55 patients with ICD-10 diagnosis of recurrent depressive disorder (F32.1), 50 patients have completely finished the treatment" Get all the results and reference details, order at left...
2.	Dysthymic Disorder 05/01/1990 - "1,231 patients with a DSM III diagnosis of major depression or dysthymic disorder were included in a long-term trial with tianeptine" 02/01/1992 - "This study evaluated the therapeutic efficacy and acceptability during long-term administration of tianeptine in depressed patients (major depressive episode or dysthymic disorder) in a multicentre trial, after withdrawal from alcohol abuse or dependence" 01/01/1988 - "129 chronic alcoholic patients, withdrawn from alcohol and presenting major depression or dysthymic disorder, were treated for 4-8 weeks under double-blind conditions either with a new antidepressant, tianeptine (37.5 mg per day), or with amitriptyline (75 mg per day)" 02/01/1992 - "The clinical properties of tianeptine have been assessed in double-blind controlled studies, which involved depressed patients fulfilling DSM-III criteria for either major depression--single episode or recurrent (without melancholia and psychotic features)--or dysthymic disorder--with or without an additional diagnosis of alcohol abuse or dependence" 03/01/1995 - "In patients with major depression without melancholia or psychotic features, depressed bipolar disorder or dysthymic disorder, the antidepressant efficacy of short term (4 weeks to 3 months) tianeptine therapy appears to be similar to that of amitriptyline, imipramine and fluoxetine and may be superior to that of maprotiline in patients with coexisting depression and anxiety" Get all the results and reference details, order at left...
3.	Bipolar Disorder (Mania) 01/01/1997 - "After a 1-week run-in placebo period, 126 depressed out-patients presenting DSM-III-R Major Depression or Bipolar Disorder, Depressed, with a total MADRS score of at least 25, were treated for 42 days with either tianeptine (25-50 mg/day) or placebo" 03/01/1995 - "The antidepressant efficacy of tianeptine, as shown in 2 trials of patients with major depression or depressed bipolar disorder with or without melancholia, is greater than that of placebo" 01/01/1997 - "The results confirmed the efficacy of tianeptine (mean dosage: 37.5 mg/day) in the treatment of Major Depression and Bipolar Disorder, Depressed, with or without melancholia, compared to placebo" 03/01/1995 - "Tianeptine was more effective in reducing psychic anxiety than placebo in patients with major depression or depressed bipolar disorder with or without melancholia" 01/01/1997 - "The efficacy and safety of tianeptine were compared, in the course of a multicentre randomised, double-blind, parallel group study, to those of placebo in the treatment of Major Depressions and Bipolar Disorder, Depressed with or without melancholia, without psychotic features" Get all the results and reference details, order at left...
4.	Alcoholism (Alcohol Abuse) 01/01/2001 - "Conclusions: The antidepressant efficacy and favourable tolerability and pharmacokinetic profiles of tianeptine in patients with depression, including those with associated anxiety, have been proven; the data indicate that it may have additional potential in specific subgroups of depressed patients such as the elderly and those with chronic alcoholism." 10/01/1997 - "Tianeptine has been shown to be active in the treatment of depression in patients with history of alcohol abuse or dependence" 11/14/1991 - "Tianeptine is an effective antidepressant in cases of depression with anxiety or alcoholism and also leads to good therapeutic response in cases of dysthemia" 11/14/1991 - "Tianeptine, a molecule with antidepressant properties, was found to affect certain learning and memory impairments induced by chronic alcoholism and aging in the mouse" 02/01/1992 - "This study evaluated the therapeutic efficacy and acceptability during long-term administration of tianeptine in depressed patients (major depressive episode or dysthymic disorder) in a multicentre trial, after withdrawal from alcohol abuse or dependence" Get all the results and reference details, order at left...
5.	Myocardial Ischemia (Ischemic Heart Diseases) 01/01/2004 - "Clinical efficacy of tianeptine in patients with ischemic heart disease and comorbid depression]" 01/01/2006 - "AIM: To study heart rate variability (HRV) according to 24-h Holter monitoring of ECG in patients with ischemic heart disease (IHD) and to examine effects of tianeptine on HRV" 01/01/2006 - "Effect of depressive state on parameters of heart rate variability in patients with ischemic heart disease and correction of revealed disturbances with antidepressant tianeptine]" 01/01/2006 - "Trends in heart rate variability in patients with ischemic heart disease and depression treated with antidepressant tianeptine]" 01/01/2004 - "Ischemic heart disease patients (20 men, 20 women, age 36-72 years) with class II-III effort angina and depression (Beck Depression Inventory -- BDI -- score > or = 19) were randomized to standard therapy were treatment of stable ischemic heart disease (control group) or standard therapy plus tianeptine 37.5 mg/day" Get all the results and reference details, order at left...
72 Diseases and 96 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Fluoxetine (Prozac)
2.	Serotonin (5 Hydroxytryptamine)
3.	Amitriptyline (Elavil)
4.	Paroxetine (Paxil)
5.	Moclobemide (Arima)
6.	Maprotiline (Ludiomil)
7.	Imipramine (Janimine)
8.	Amlodipine (Norvasc)
9.	Morphine (MS Contin)
10.	Corticosterone
47 Drugs and Important Bio-Agents and 49 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Ligation
1 Therapies and Procedures and 2 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>